CancerMedPage Today

Adjuvant Checkpoint Inhibition in Urothelial Cancer

Several studies at the 2021 virtual American Society of Clinical Oncology (ASCO) annual meeting were focused on the increased use of immune checkpoint inhibitors across various settings in urothelial bladder cancer. In this video, courtesy of VJHemOnc, Srikala S. Sridhar, MD, of Princess Margaret Hospital in Toronto, Canada, gives a...
Picture for Adjuvant Checkpoint Inhibition in Urothelial Cancer
Mckinney, TXPosted by
DFW Community News

Ambassador Spotlight - Clint Scofield

I have been a LegalShield Director since 2001. I began my business working one-on-one with individuals, moving in later years to Corporate HR Directors along with their employees and, currently, working with Benefit Brokers who provide our voluntary, ancillary benefits to their corporate clients’ employees. Our LegalShield and IDShield benefits are one of a kind and provide quick, affordable, comprehensive services to resolve today’s everyday issues for individuals, families, and businesses.